| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/19/2004 | WO2004069259A1 Remedy for diabetes |
| 08/19/2004 | WO2004069243A1 Breast cancer resistance protein (bcrp) inhibitor |
| 08/19/2004 | WO2004069238A1 Drug for improving prognosis for subarachnoid hemorrhage |
| 08/19/2004 | WO2004069236A1 Inhibitor for perioperative blood sugar elevation |
| 08/19/2004 | WO2004069233A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | WO2004069142A2 Anti-candida agents for the treatment of prion diseases |
| 08/19/2004 | WO2004054356A3 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 08/19/2004 | WO2004006756A3 THERAPIES FOR RENAL FAILURE USING INTERFERON-β |
| 08/19/2004 | WO2003094853A3 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 08/19/2004 | WO2003092585A3 Controlled release compositions of estradiol metabolites |
| 08/19/2004 | WO2003088958A3 Combinations of cox-2 inhibitors and other agents for the treatment of parkinson’s disease |
| 08/19/2004 | WO2003077834A3 Central airway administration for systemic delivery of therapeutics |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003051886A8 Pyrazolopyridazine derivatives |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 08/19/2004 | WO2002089778A3 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 08/19/2004 | US20040162427 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162415 growth and activity promotion effects on osteoblasts |
| 08/19/2004 | US20040162410 Thrombosis therapy; anticoagulants |
| 08/19/2004 | US20040162353 Alpha-difluoromethylornithine(DFMO) suppresses polyamine levels in the human prostate |
| 08/19/2004 | US20040162348 Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
| 08/19/2004 | US20040162332 serotonin receptor ligands such as 6-(phenylsulfonyl)-2,3,4,9-tertrahydro-1H-carbazol-3-amine, used for prophylaxis of anxiety, depression, schizophrenia, Alzheimer's disease, panic, phobia, obsessive compulsive disorder, obesity, post-traumatic stress syndrome, epilepsy and nervous system disorders |
| 08/19/2004 | US20040162324 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments |
| 08/19/2004 | US20040162319 For prophylaxis and therapy of thrombotic conditions including coronary artery and cerebrovascular diseases |
| 08/19/2004 | US20040162316 Combination treatment for alcoholism and alcohol dependence |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162312 NMDA NR2B antagonists for treatment |
| 08/19/2004 | US20040162304 Estrogen receptor modulators |
| 08/19/2004 | US20040162302 Novel crystal of arylethenesulfonamide derivative and preparation process thereof |
| 08/19/2004 | US20040162295 Pharmaceutical compound |
| 08/19/2004 | US20040162291 For therapy of cardiovascular disorders and erectile dysfunction |
| 08/19/2004 | US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162276 Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology |
| 08/19/2004 | US20040162274 Inhibition of steroid synthesis by use of progesterone or a progesterone receptor agonist |
| 08/19/2004 | US20040162271 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 08/19/2004 | US20040162244 Novel peptides use as angiotensin converting enzyme inhibitor and preparation process thereof |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161456 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes |
| 08/19/2004 | US20040161430 Dye-azide compounds for dual phototherapy |
| 08/19/2004 | US20040161407 Medicinal compositions |
| 08/19/2004 | US20040161405 Guanidinium transport reagents and conjugates |
| 08/19/2004 | US20040161393 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| 08/19/2004 | US20040161385 Delivery of beta-blockers through an inhalation route |
| 08/19/2004 | US20040160876 Method for determining a tilt angle of an optical pickup head |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | DE10142663B4 C2-Disubstituierte Indan-1-ol-Systeme C2-Disubstituted indan-1-ol systems |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | CA2515516A1 Carboxylic acid compounds |
| 08/19/2004 | CA2515294A1 Therapeutic agents for diabetes |
| 08/19/2004 | CA2515174A1 Breast cancer resistance protein (bcrp) inhibitor |
| 08/19/2004 | CA2515135A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | CA2515119A1 Pyrazole derivative |
| 08/19/2004 | CA2513109A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/18/2004 | EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 08/18/2004 | EP1447402A1 Quinoline compound |
| 08/18/2004 | EP1447400A1 Bicyclic compound |
| 08/18/2004 | EP1447096A1 Remedies for urinary frequency |
| 08/18/2004 | EP1447091A1 Novel method of inducing antigen-specific t cells |
| 08/18/2004 | EP1447087A1 Superfine aqueous dispersion of noble metal for head massage |
| 08/18/2004 | EP1447086A1 An aqueous metal bicarbonate solution and method of use |
| 08/18/2004 | EP1447085A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator |
| 08/18/2004 | EP1447083A1 Preventives/remedies for viral infection |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446418A2 Integrin targeting compounds |
| 08/18/2004 | EP1446417A2 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 08/18/2004 | EP1446411A1 Acarbose purification process |
| 08/18/2004 | EP1446407A2 (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 08/18/2004 | EP1446405A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/18/2004 | EP1446401A2 C-5 modified indazolylpyrrolotriazines |
| 08/18/2004 | EP1446399A1 Piperazine derivatives having sst1 antagonistic activity |
| 08/18/2004 | EP1446394A1 NOVEL 1,2,4−THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446392A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 08/18/2004 | EP1446391A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 08/18/2004 | EP1446388A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 08/18/2004 | EP1446386A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control |
| 08/18/2004 | EP1446385A1 Preparation and use of substituted imidazoles |
| 08/18/2004 | EP1446384A1 Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same |
| 08/18/2004 | EP1446382A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 08/18/2004 | EP1446161A2 Medicinal combination of biguanine (metformin) and arginine |
| 08/18/2004 | EP1446159A2 Immunotherapy for reversing immune suppression |
| 08/18/2004 | EP1446155A1 Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides |
| 08/18/2004 | EP1446150A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
| 08/18/2004 | EP1446146A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 08/18/2004 | EP1446136A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/18/2004 | EP1446133A2 Methods of improving central nervous system functioning |
| 08/18/2004 | EP1446132A2 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives |
| 08/18/2004 | EP1446125A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/18/2004 | EP1446122A1 Use of flibanserin in the treatment of sexual disorders |
| 08/18/2004 | EP1446118A1 Oral dosage form of a sulfonamide prodrug such as parecoxib |
| 08/18/2004 | EP1446117A2 Treatment of acute myeloid leukemia with indolinone compounds |
| 08/18/2004 | EP1446116A1 Inhibitors of dipeptidyl peptidase iv |
| 08/18/2004 | EP1446115A2 Cyanoalkylamino derivatives as protease inhibitors |
| 08/18/2004 | EP1446112A1 USE OF GLUTAMATE, GLUTAMATE DERIVATIVES OR METABOLITES, GLUTAMATE ANALOGUES OR MIXTURES THEREOF FOR THE MANUFACTURE OF A COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS |
| 08/18/2004 | EP1446110A2 Organosulfur inhibitors of tyrosine phosphatases |
| 08/18/2004 | EP1446101A2 Catheter injectable depot compositions and uses thereof |